✦ LIBER ✦

PCV61 Pharmacoeconomic Evaluation of Olmesartan, Losartan and Valsartan in Treatment of Essential Arterial Hypertension

✍ Scribed by S.G. Gorokhova; V.V. Ryazhenov

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative Efficacy of Olmesartan, Losa

✍ Suzanne Oparil; David Williams; Steven G. Chrysant; Thomas C. Marbury; Joel Neut 📂 Article 📅 2001 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 985 KB

PCV65 PHARMACOECONOMIC ANALYSIS OF 160MG

✍ JA Guzman; F Carlos; D Dector; A Camacho; F Fon; C Castillejos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Comparison of Increasing Doses of Olmesa

✍ Thomas D. Giles; Suzanne Oparil; Tonous N. Silfani; Antonia Wang; J. Findlay Wal 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 290 KB

PCV66 Pharmacoeconomic Analysis of Azils

✍ A.J. Zamora Muciño-Arroyo; J.G. Gay-Molina; J. Chiu-Ugalde; A. Figueroa-Rodrigue 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Comparison of ascending doses of olmesar

✍ Thomas Giles; Suzanne Oparil; Tonous Silfani; Findlay Walker 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

A comparison of the angiotensin II antag

✍ Thomas Hedner; Suzanne Oparil; Knud Rasmussen; Alessandro Rapelli; Marjorie Gatl 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB